Concepedia

Wen Shi

WS

Statistics

Publications

7

Citations

176

H-Index

7

Active since

2004

Affiliations

Fudan University(Current)

The US Oncology Network

Virginia Cancer Specialists

Taizhou University

McGill University

Wen Shi is an author at Fudan University specializing in autoimmune disease, rheumatic diseases, and rheumatology.

ORCID

Top concepts

Publications per year

2004–2023

7

Publications

7

An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma

David Andorsky, Kathryn S. Kolibaba, Sarit Assouline et al. · British Journal of Haematology · 2018 · 47 citations · Full text

An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma

John M. Burke, Andrei R. Shustov, James Essell et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 41 citations · Full text

<p>Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients</p>

Wen Shi, Juan Wu, Qi Tan et al. · Infection and Drug Resistance · 2019 · 22 citations · Full text

Mechanisms of oral absorption improvement for insoluble drugs by the combination of phospholipid complex and SNEDDS

Yingpeng Tong, Qin Zhang, Wen Shi et al. · Drug Delivery · 2019 · 21 citations · Full text

Safety and Efficacy of Oral Nonsteroidal Anti-Inflammatory Drugs in Patients with Rheumatoid Arthritis

Wen Shi, Yong Ming Wang, Li Shao Li et al. · Clinical Drug Investigation · 2004 · 20 citations

, , +10

1–5 of 7